Fig. 4.
In vivo global ischemia results in reduced potentiation of IPSC decay kinetics. (A) Representative recording showing prolongation of the decay kinetics of the IPSC before (control) and after application of etomidate (3 µm). (B) Summary of IPSC decay time constant (ms) in control conditions in sham and CA/CPR. (C) Summary of IPSC decay time constant in the presence of etomidate. Mean ± SEM; *P < 0.05.
